Saba Capital Management’s PepperLime Health Acquisition Corporation Class A Ordinary Share PEPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-295,760
Closed -$3.02M 848
2022
Q4
$3.02M Buy
295,760
+57
+0% +$575 0.04% 459
2022
Q3
$2.95M Hold
295,703
0.03% 595
2022
Q2
$2.92M Hold
295,703
0.03% 616
2022
Q1
$2.91M Buy
295,703
+5,786
+2% +$56.8K 0.04% 529
2021
Q4
$2.84M Buy
+289,917
New +$2.83M 0.04% 475

Other funds holding PEPL

Saba Capital Management's PEPL Position: Q1 2023 in Review

Saba Capital Management sold out of PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) in Q1 2023, closing a stake of 295,760 shares — an estimated $3.02M sold.

Saba Capital Management first reported a position in PEPL in Q4 2021 and held it in 5 quarters. The position peaked at $3.02M in Q4 2022. 15 funds tracked by Wall St. Rank hold PEPL as of Q1 2023.

  • Saba Capital Management reported no remaining PepperLime Health Acquisition Corporation Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
  • Saba Capital Management sold 295,760 PepperLime Health Acquisition Corporation Class A Ordinary Share shares in Q1 2023, an estimated $3.02M.
  • Saba Capital Management first reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share in Q4 2021 and held it in 5 quarters.
  • Saba Capital Management's PepperLime Health Acquisition Corporation Class A Ordinary Share position peaked at $3.02M in Q4 2022.
  • 15 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Class A Ordinary Share as of Q1 2023.

Based on Saba Capital Management's 13F filing for Q1 2023, filed 15 May 2023.